MicroRNA-324-3p promotes renal fibrosis and is a target of ACE inhibition
about
Key fibrogenic mediators: old players. Renin–angiotensin systemN-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetesMicroRNA-184 is a downstream effector of albuminuria driving renal fibrosis in rats with diabetic nephropathyMicroRNA-194 (miR-194) regulates ROMK channel activity by targeting intersectin 1.Urinary microRNA profiling in the nephropathy of type 1 diabetes.microRNAs Involved in Regulating Spontaneous Recovery in Embolic Stroke Model.Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients.Comparison of different normalization strategies for the analysis of glomerular microRNAs in IgA nephropathy.The regulation and function of microRNAs in kidney diseases.Stability of miRNA in human urine supports its biomarker potential.miR-324-3p suppresses migration and invasion by targeting WNT2B in nasopharyngeal carcinoma.Deciphering microRNA code in pain and inflammation: lessons from bladder pain syndrome.MicroRNAs in kidney diseases: new promising biomarkers for diagnosis and monitoring.Hypertension and kidneys: unraveling complex molecular mechanisms underlying hypertensive renal damage.MicroRNAs: potential regulators of renal development genes that contribute to CAKUT.The emergence of the glomerular parietal epithelial cell.Role of microRNA machinery in kidney fibrosis.MicroRNAs: potential therapeutic targets in diabetic complications of the cardiovascular and renal systems.Causes and pathogenesis of focal segmental glomerulosclerosis.MicroRNA21 promotes interstitial fibrosis via targeting DDAH1: a potential role in renal fibrosis.MicroRNAs as Master Regulators of Glomerular Function in Health and Disease.MicroRNA expression profiling in patients with hepatocellular carcinoma of familial aggregation and hepatitis B virus infection.Delivery of microRNA-146a with polyethylenimine nanoparticles inhibits renal fibrosis in vivo.Decreased expression of microRNA-29 family in leiomyoma contributes to increased major fibrillar collagen production.Effect of Antifibrotic MicroRNAs Crosstalk on the Action of N-acetyl-seryl-aspartyl-lysyl-proline in Diabetes-related Kidney FibrosisThe expression of microRNA-324-3p as a tumor suppressor in nasopharyngeal carcinoma and its clinical significance.A microarray analysis of urinary microRNAs in renal diseases.MicroRNA-410 is involved in mitophagy after cardiac ischemia/reperfusion injury by targeting high-mobility group box 1 protein.Therapeutic potential of microRNAs for the treatment of renal fibrosis and CKD.The Role of MicroRNAs in Kidney Disease.Stabilization of Urinary MicroRNAs by Association with Exosomes and Argonaute 2 Protein.miR-374a Regulates Inflammatory Response in Diabetic Nephropathy by Targeting MCP-1 Expression
P2860
Q26796631-DB89263F-BE2F-4495-B1FA-2219BE3FFEEFQ27008887-38D4C221-AA21-4D70-81F4-C2D4839CEA55Q33653982-8696FF6A-5E91-48E1-B864-6C1FF754B8E1Q34382992-C3695048-9B33-49FC-B78D-94A30E25073DQ34566051-199F1BB6-946D-4C71-8853-8777319E5489Q34792605-FC8AE9FD-C2FE-4ED5-B4DD-ABCBC6F7ED4FQ35940910-F3B2D55D-D572-4157-8CB1-3A39482E028DQ36110820-43AD2E5C-306B-4894-B42F-8F1FF2DC4CB1Q36960910-EDFBA92D-6048-4236-A198-BA0293E1F361Q37450795-4DD2377D-2593-4577-804E-BBF0FF614CB9Q37554826-AA431E3E-A5FC-489B-9861-CECB09F0FA05Q38086764-D5EC64DC-D78C-462B-A2B4-21CC88AF4174Q38115932-C9E08363-FCA8-4841-824D-93DD9D7C5CCEQ38117232-F1E4173E-6D64-472F-8BFE-81F63424607BQ38133419-A327B3BD-F7E3-45FA-9EFF-4E98E2E723E3Q38182323-D67F61B5-B91D-459A-A80D-54D578B1943DQ38209551-A4F21000-8AC7-4C5E-8F23-A3A2064CC907Q38212459-244E0BAF-7168-4420-8A4A-8D67D83B13F3Q38275115-C6AA3988-E3DC-403F-A9C1-593F4CC96976Q38828896-CFF5B7D5-5BAC-45E2-9972-1138F0F0A908Q39148575-FEBEDD3B-5CC9-4B1D-80C3-B953019E1F66Q40128942-67D8E663-86F8-432A-B2F8-F209663D2705Q40775844-EA650AF8-752C-4A25-874E-F075AFA06060Q41013033-6E20102C-DC16-42A5-BEDC-0926C7D9F21AQ41832445-DBDD3183-FFAB-4874-885A-A4EBD191742DQ42687962-97721E71-23B2-42E2-B1E7-A2A8C38F465EQ46800303-C0ECEC5E-D080-427E-9EBF-AF5A1029CA00Q47670824-17B89B74-F693-40DE-8FCD-422FE71BC264Q50063239-F8762FA6-96AE-420C-B49A-ACDD95AD4C11Q54964308-0C578C05-93CA-432B-BFC5-1E29E62F0979Q55065698-2E8CF051-A5A2-4D6C-911D-0E5531FB904CQ58790149-66543411-53BE-4656-B5BF-A302ADA79E3F
P2860
MicroRNA-324-3p promotes renal fibrosis and is a target of ACE inhibition
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
MicroRNA-324-3p promotes renal fibrosis and is a target of ACE inhibition
@ast
MicroRNA-324-3p promotes renal fibrosis and is a target of ACE inhibition
@en
MicroRNA-324-3p promotes renal fibrosis and is a target of ACE inhibition
@nl
type
label
MicroRNA-324-3p promotes renal fibrosis and is a target of ACE inhibition
@ast
MicroRNA-324-3p promotes renal fibrosis and is a target of ACE inhibition
@en
MicroRNA-324-3p promotes renal fibrosis and is a target of ACE inhibition
@nl
prefLabel
MicroRNA-324-3p promotes renal fibrosis and is a target of ACE inhibition
@ast
MicroRNA-324-3p promotes renal fibrosis and is a target of ACE inhibition
@en
MicroRNA-324-3p promotes renal fibrosis and is a target of ACE inhibition
@nl
P2093
P2860
P50
P356
P1476
MicroRNA-324-3p promotes renal fibrosis and is a target of ACE inhibition
@en
P2093
Daniela Macconi
Fabio Sangalli
Mauro Abbate
Paola Rizzo
Piera Trionfini
Susanna Tomasoni
P2860
P304
P356
10.1681/ASN.2011121144
P577
2012-07-19T00:00:00Z